Article Information
History
- March 27, 2020.
Article Versions
- You are currently viewing Version 1 of this article (March 27, 2020 - 02:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Wen Wen1,*,
- Wenru Su2,*,
- Hao Tang3,5,*,
- Wenqing Le4,*,
- Xiaopeng Zhang5,*,
- Yingfeng Zheng2,*,
- Xiuxing Liu2,
- Lihui Xie2,
- Jianmin Li5,
- Jinguo Ye2,
- Xiuliang Cui1,
- Yushan Miao3,
- Depeng Wang6,
- Jiantao Dong7,
- Chuanle Xiao2,*,#,
- Wei Chen5,# and
- Hongyang Wang1,9,10,#
- 1National Center for Liver Cancer, Second Military Medical University, Shanghai, China
- 2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
- 3Department of Respiratory and Critical Care Medicine Changzheng Hospital, Second Military Medical University, Shanghai, China
- 4Department of Critical Care, Wuhan Hankou Hospital, Hubei, China
- 5Department of Critical Care, Wuhan Huo Shen Shan Hospital, Hubei, China
- 6Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, China
- 7GrandOmics Biosciences Co. Ltd., Beijing, China
- 8Berry Genomics Co. Ltd., Beijing, China
- 9Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
- 10Ministry of Education (MOE) Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Second Military Medical University, Shanghai, China
- ↵#Correspondence to: Dr. Chuanle Xiao (xiaochuanle{at}126.com), Hongyang Wang (hywangk{at}vip.sina.com) or Wei Chen (cw0226{at}foxmail.com)
↵* These authors contributed equally to this work.